Leonard Sender

Title: Leonard Sender: Innovator in Vaccine Development

Introduction

Leonard Sender is a prominent inventor based in Culver City, California. He has made significant contributions to the field of vaccine development, particularly in the fight against coronaviruses. With a total of two patents to his name, Sender's work focuses on innovative methods for inducing immunity against viral infections.

Latest Patents

Sender's latest patents include groundbreaking work on SARS-CoV-2 vaccines that utilize human adenovirus vectors. These vaccines are designed to encode spike and nucleocapsid-ETSD immunogens. The disclosed methods aim to induce immunity in the mucosal tissue of patients through various forms of oral administration, such as nasal injection and inhalation. Additionally, the patents describe compositions for assaying the presence of anti-viral antibodies and viral proteins in saliva samples, which may include stabilizing solutions and aragonite particle beads. The recombinant entities presented in these patents are bivalent, comprising nucleic acids that encode both the CoV2 nucleocapsid protein and an optimized spike protein sequence for effective cell surface expression.

Career Highlights

Leonard Sender has established himself as a key figure in the biotechnology sector, particularly through his work at ImmunityBio, Inc. His innovative approaches to vaccine development have positioned him at the forefront of research aimed at combating viral diseases.

Collaborations

Sender collaborates with notable figures in the industry, including Patrick Soon-Shiong and Peter Sieling. These partnerships enhance the potential impact of his research and contribute to the advancement of vaccine technologies.

Conclusion

Leonard Sender's contributions to vaccine development, particularly in relation to SARS-CoV-2, highlight his role as an influential inventor in the field. His innovative patents and collaborations continue to pave the way for advancements in immunization strategies.